Subscribe
Coke Morgan Stewart, Acting Under Secretary of Commerce for IP and Acting Director of the USPTO
10 June 2025NewsAmericasMuireann Bolger

USPTO’s Stewart: Don’t nix patents as penalty for misconduct

Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
5 June 2025   Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel.
Careers
Acting USPTO director sworn in moments after Trump takes office
23 January 2025   ‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Big Pharma
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
5 June 2025   Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel.
Careers
Acting USPTO director sworn in moments after Trump takes office
23 January 2025   ‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade.

More on this story

Big Pharma
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
5 June 2025   Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel.
Careers
Acting USPTO director sworn in moments after Trump takes office
23 January 2025   ‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade.

More features

Fed Circ affirms rulings in Acadia’s fight against Parkinson’s drug copies
Fed Circ upholds Moderna’s COVID-19 vaccine win against Alnylam
‘Choose your IP armour carefully’: Novartis, HP, Nestlé and Vidal
Wilson Sonsini adds veteran USPTO examiner as senior patent counsel
Make your voice heard: Call for input on AI, the UPC, and patent trends
J&J unit could owe biotech $125m over AI-based surgical ‘night vision’ tech
FisherBroyles appoints biotech-focused partner in DC
Crowell & Moring and Faber Daeufer launch life sciences practice